Search

Search Constraints

You searched for: Author/Creator Schots, Rik

Search Results

2. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

3. Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. (28th March 2017)

4. Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial. Issue 12 (30th September 2013)

5. Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial. Issue 12 (30th September 2013)

6. Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. (September 2013)

8. Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review. (30th September 2022)

9. Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia‐positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation. (25th June 2014)

10. Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking. Issue 2 (9th August 2021)